drugset / Trial / NCT02434276
Study of the Immunogenicity and Safety of a Quadrivalent Influenza Vaccine (VAX2012Q) in Adults 18-64 Years
Phase 2
Unknown
450 enrolled
VaxInnate Corporation
Accelovance · collabDepartment of Health and Human Services · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This is a multi-center, randomized, double-blind, active comparator controlled study in which up to 450 healthy adults age 18-64 years will be administered either one of two dose levels of VAX2012Q or a licensed quadrivalent influenza vaccine. The subjects will be randomized at a 1:1:1 ratio.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-08
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Influenza Virus Vaccine | Vaccine | — | — |
| Subject | VAX2012Q | Vaccine | 8 ug | — |
| Subject | VAX2012Q | Vaccine | 12 ug | — |